Healthcare & Life Sciences
Galvanize Therapeutics
aliveseries-c
series-c
Stage
1
Investors
About
Develops the Aliya® pulsed electric field (PEF) ablation system, a medical device designed to treat cancer and chronic lung disease, with clinical trials focused on late-stage non-small cell lung cancer and lung metastases.
Explore Galvanize Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.